Industry & Policy News

[Columbia University] Two IICD faculty members, Elham Azizi - Herbert and Florence Irving Assistant Professor of Cancer Data Research and Assistant Professor of Biomedical Engineering - and José McFaline-Figueroa - Assistant Professor of Biomedical Engineering -, are among the 18 new Allen Distinguished Investigators.

[bit.bio (BusinessWire, Inc.)] bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London today announce a collaboration to build multi-cell models of the human brain using bit.bio’s ioCells™️.

[STAT News] Just 3% of more than 3,700 studies run exclusively in Canada over a recent 10-year period were registered prospectively, reported results, and published the findings, underscoring ongoing concerns about clinical trial transparency, according to a new analysis.

[FierceBiotech] The data come from a Phase III clinical trial of pelabresib, a BET inhibitor that MorphoSys acquired in its $1.7 billion acquisition of Constellation Pharmaceuticals.

[THE MARFAN FOUNDATION] The Marfan Foundation awarded five new two-year research grants include two Innovator Awards and three Victor McKusick Fellowship Awards. The research projects focus on aortic dissection and thoracic aortic aneurysms.

[International Vaccine Institute] The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) signed a memorandum of understanding for global vaccine research collaboration.